PubMed:24371021
Annnotations
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 204-244 | HP_0007018 | denotes | attention deficit hyperactivity disorder |
| T2 | 204-221 | HP_0007018 | denotes | attention deficit |
| T3 | 222-235 | HP_0000752 | denotes | hyperactivity |
NEUROSES
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-29 | CHEBI_31836 | denotes | Methylphenidate hydrochloride |
| T3 | 124-129 | PATO_0001177 | denotes | blind |
| T4 | 535-540 | PATO_0001177 | denotes | blind |
| T5 | 580-585 | PATO_0001177 | denotes | blind |
| T6 | 800-805 | PATO_0001177 | denotes | blind |
| T7 | 852-857 | PATO_0001177 | denotes | blind |
| T8 | 256-263 | PATO_0000392 | denotes | limited |
| T9 | 559-564 | PATO_0000083 | denotes | phase |
| T10 | 732-737 | PATO_0000083 | denotes | phase |
| T11 | 828-833 | PATO_0000083 | denotes | phase |
| T12 | 910-915 | PATO_0000083 | denotes | phase |
| T13 | 1147-1152 | PATO_0000083 | denotes | phase |
| T15 | 1491-1496 | PATO_0000083 | denotes | phase |
| T16 | 1879-1884 | PATO_0000083 | denotes | phase |
| T17 | 586-592 | PATO_0001309 | denotes | period |
| T18 | 611-617 | PATO_0001309 | denotes | period |
| T19 | 761-767 | PATO_0001309 | denotes | period |
| T20 | 626-631 | PATO_0000300 | denotes | fixed |
| T21 | 1039-1042 | CHEBI_38624 | denotes | DSM |
| T22 | 1561-1564 | CHEBI_38624 | denotes | DSM |
| T23 | 1085-1088 | CHEBI_8984 | denotes | SDS |
| T24 | 1613-1616 | CHEBI_8984 | denotes | SDS |
| T25 | 1161-1171 | PATO_0000063 | denotes | percentage |
| T26 | 1957-1967 | PATO_0000063 | denotes | percentage |
| T27 | 2066-2076 | PATO_0000063 | denotes | percentage |
| T28 | 1758-1765 | PATO_0001511 | denotes | failure |
| T29 | 1766-1770 | PATO_0001470 | denotes | rate |
| T30 | 1766-1770 | PATO_0000161 | denotes | rate |
| T31 | 1905-1915 | PATO_0000990 | denotes | consistent |
| T32 | 2193-2203 | PATO_0001510 | denotes | functional |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_24371021_2_0 | 204-244 | expanded | denotes | attention deficit hyperactivity disorder |
| SS2_24371021_2_0 | 246-250 | abbr | denotes | ADHD |
| SS1_24371021_3_0 | 342-388 | expanded | denotes | methylphenidate hydrochloride modified-release |
| SS2_24371021_3_0 | 390-396 | abbr | denotes | MPH-LA |
| SS1_24371021_8_0 | 963-1037 | expanded | denotes | Diagnostic and Statistical Manual of Mental Disorders-IV ADHD Rating Scale |
| SS2_24371021_8_0 | 1039-1053 | abbr | denotes | DSM-IV ADHD RS |
| SS1_24371021_8_1 | 1059-1083 | expanded | denotes | Sheehan Disability Scale |
| SS2_24371021_8_1 | 1085-1088 | abbr | denotes | SDS |
| AE1_24371021_2_0 | SS1_24371021_2_0 | SS2_24371021_2_0 | abbreviatedTo | attention deficit hyperactivity disorder,ADHD |
| AE1_24371021_3_0 | SS1_24371021_3_0 | SS2_24371021_3_0 | abbreviatedTo | methylphenidate hydrochloride modified-release,MPH-LA |
| AE1_24371021_8_0 | SS1_24371021_8_0 | SS2_24371021_8_0 | abbreviatedTo | Diagnostic and Statistical Manual of Mental Disorders-IV ADHD Rating Scale,DSM-IV ADHD RS |
| AE1_24371021_8_1 | SS1_24371021_8_1 | SS2_24371021_8_1 | abbreviatedTo | Sheehan Disability Scale,SDS |
yangbin123xm_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 204-244 | DP | denotes | attention deficit hyperactivity disorder |
| T2 | 62-102 | DP | denotes | attention deficit hyperactivity disorder |
| T3 | 246-250 | DP | denotes | ADHD |
| T4 | 413-417 | DP | denotes | ADHD |
| T5 | 1020-1024 | DP | denotes | ADHD |
| T6 | 1046-1050 | DP | denotes | ADHD |
| T7 | 1568-1572 | DP | denotes | ADHD |
| T8 | 2225-2229 | DP | denotes | ADHD |
| T9 | 342-388 | CI | denotes | methylphenidate hydrochloride modified-release |
| T10 | 390-396 | CI | denotes | MPH-LA |
| T11 | 460-466 | CI | denotes | MPH-LA |
| T12 | 660-666 | CI | denotes | MPH-LA |
| T13 | 1346-1352 | CI | denotes | MPH-LA |
| T14 | 1734-1740 | CI | denotes | MPH-LA |
| T15 | 1800-1806 | CI | denotes | MPH-LA |
| T16 | 1937-1943 | CI | denotes | MPH-LA |
| T17 | 2021-2027 | CI | denotes | MPH-LA |
| T18 | 2109-2115 | CI | denotes | MPH-LA |
| T19 | 2134-2140 | CI | denotes | MPH-LA |
| T20 | 0-46 | CI | denotes | Methylphenidate hydrochloride modified-release |
chenxin_473849_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 204-244 | DP | denotes | attention deficit hyperactivity disorder |
| T2 | 62-102 | DP | denotes | attention deficit hyperactivity disorder |
| T3 | 246-250 | DP | denotes | ADHD |
| T4 | 413-417 | DP | denotes | ADHD |
| T5 | 1020-1024 | DP | denotes | ADHD |
| T6 | 1046-1050 | DP | denotes | ADHD |
| T7 | 1568-1572 | DP | denotes | ADHD |
| T8 | 2225-2229 | DP | denotes | ADHD |
| T9 | 660-666 | CI | denotes | MPH-LA |
| T10 | 390-396 | CI | denotes | MPH-LA |
| T11 | 460-466 | CI | denotes | MPH-LA |
| T12 | 1346-1352 | CI | denotes | MPH-LA |
| T13 | 1734-1740 | CI | denotes | MPH-LA |
| T14 | 1800-1806 | CI | denotes | MPH-LA |
| T15 | 1937-1943 | CI | denotes | MPH-LA |
| T16 | 2021-2027 | CI | denotes | MPH-LA |
| T17 | 2109-2115 | CI | denotes | MPH-LA |
| T18 | 2134-2140 | CI | denotes | MPH-LA |
| T19 | 342-388 | CI | denotes | methylphenidate hydrochloride modified-release |
| T20 | 0-46 | CI | denotes | Methylphenidate hydrochloride modified-release |